Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
6,972
+166
+2% +$27K 0.07% 67
2025
Q4
$1.33M Hold
6,806
0.09% 63
2025
Q3
$1.91M Sell
6,806
-86
-1% -$21.9K 0.12% 57
2025
Q2
$1.51M Sell
6,892
-20
-0.3% -$3.23K 0.11% 62
2025
Q1
$966K Buy
6,912
+180
+3% +$29.3K 0.08% 75
2024
Q4
$1.12M Buy
6,732
+596
+10% +$106K 0.08% 69
2024
Q3
$1.05M Hold
6,136
0.08% 68
2024
Q2
$866K Hold
6,136
0.07% 72
2024
Q1
$771K Buy
6,136
+400
+7% +$45.8K 0.06% 73
2023
Q4
$605K Sell
5,736
-40
-0.7% -$4.37K 0.06% 78
2023
Q3
$612K Sell
5,776
-500
-8% -$57.9K 0.06% 74
2023
Q2
$747K Hold
6,276
0.07% 73
2023
Q1
$583K Buy
+6,276
New +$550K 0.06% 78

Other funds holding ORCL

Avalon Trust's ORCL Position: Q1 2026 in Review

Avalon Trust increased its Oracle (ORCL) stake by 2.4% in Q1 2026, buying an estimated $27K and bringing the position to 6,972 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #67.

Avalon Trust first reported a position in ORCL in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.91M in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Avalon Trust held 6,972 shares of Oracle worth $1.03M as of Q1 2026.
  • Avalon Trust bought 166 Oracle shares in Q1 2026, an estimated $27K.
  • Oracle made up 0.07% of Avalon Trust's portfolio in Q1 2026, its #67 holding.
  • Avalon Trust first reported a position in Oracle in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Oracle position peaked at $1.91M in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.